Last week, Dr. Ruth Fisher was invited back to the Periodic Effects podcast. The episode, "Pe153 Cannabis 2.0 Markets, Trends & Patents," discusses the following:
Cannabis 2.0 is the new buzz word for the next “Wave” of evolution in cannabis markets. Will corporate cannabis dominate the industry? Will governments put up huge barriers to entry with regulations? How are patents currently being used in cannabis?
Dr. Fisher was recently interviewed for the TSC Talks podcast, a regular discussion about the treatment of Tuberous Sclerosis Complex.
Ruth describes the experiences that shaped her and the skills she developed that enabled her to understand how cannabis works in the body. She also discusses why it’s difficult to make sense of the information available and why the evidence seeking to establish cannabis safety and efficacy is not available.
Today, Dr. Fisher delivered the opening keynote speech for Cannabis on The Blockchain. She delivered a thirty-thousand-foot view about the adoption of cannabis science and technology at The Blockchain Event in Fort Lauderdale, February 11-14th, 2020.
"Hi there Dr. Fisher! I am a nurse and midwife in Florida and have been in the health care industry for over 40 years. Most recently, I have been transitioning into the field of cannabis nursing in order to provide education for medical cannabis patients and consumers. Over the past 5 months I have read approximately 20 books from industry experts and attended numerous seminars and webinars. I have visited every dispensary within a 50-mile radius of my community and am also a member of the American Cannabis Nurses Association. I am writing to say 'thank you'.
The short film, Schedule 1, was screened this week amid a panel of cannabis experts and a theater full of a captivated audience. Filmgoers were presented with a documentary with case studies demonstrating the tumor reduction properties of cannabis. The film was followed by a panel of experts discussing the evidence of cannabis's anti-cancer effects.
Dr. Fisher participated on the panel, where she discussed subjects such as the "whole-plant" effect and the entourage effect.
Research Team Lead at CannaLytica, Jon Calder, recently reviewed The Medical Cannabis Primer. The reivew is available on both LinkedIn.com and Medium.com. This one is much more sophisticated than previous reviews. Thank you, Mr. Calder, for taking the time to dig in deep.
[This book is] well-referenced and researched, across topics including “the controversy,” basic Cannabis botany, cannabinoid pharmacology, Medical Cannabis indications, and counter-indications, consumer awareness of the often less than ethical CannaBusiness, and, what makes this text worth the price alone, a fantastic chapter dealing with “The Evidence.”
The CED Foundation has given their endorsement of The Medical Cannabis Primer. Created in 2017, the CED Foundation is dedicated to combating, through education and information, stigmas associated with the usage of cannabis.
The endorsement is short and to the point:
Ruth Fisher, PhD (https://www.linkedin.com/in/rfisher/) published a wonderful compilation of introductory cannabis info, rich summaries of cannabis literature, wrapped nicely in a gorgeous soft cover layout, and stunning photography. 2 thumbs up for “The Medical Cannabis Primer” !
Arts & entertainment newspaper, The Santa Barbara Independent has published a glowing review of The Medical Cannabis Primer. The Indy's Senior Editor, Tyler Hayden did a great job in telling the story about how and why this book was developed, and he discusses some of the big hurdles that author Ruth Fisher, PhD jumped to publish this compendium.
"The Medical Cannabis Primer" Cuts Through the Crap
New Book Helps Novice Patients Choose Their Right Medicine
- Created on .